Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
+1.99M
-
Total reported value, excl. options
-
$78.6M
-
Value change
-
+$9.45M
-
Put/Call ratio
-
0.23
-
Number of buys
-
53
-
Number of sells
-
-26
-
Price
-
$4.90
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q2 2024
108 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q2 2024.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 53.4M outstanding shares and own 30.03% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.7M shares), Nantahala Capital Management, LLC (2.42M shares), VANGUARD GROUP INC (1.83M shares), Altium Capital Management LP (1.16M shares), Woodline Partners LP (1.15M shares), GEODE CAPITAL MANAGEMENT, LLC (914K shares), 683 Capital Management, LLC (800K shares), STATE STREET CORP (720K shares), Retirement Planning Co of New England, Inc. (458K shares), and Janney Montgomery Scott LLC (433K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.